Trinity Capital Inc. Provides $60 Million in Growth Capital to Metabolon
Metabolon develops scientific, technological, and bioinformatics techniques to measure inputs from internal and external factors such as health, disease, nutrition, microbiome, medication, and environmental exposure, to help answer scientific questions about health and disease. Metabolon's customizable metabolomics solutions support research in the biopharma, population health, consumer products, agriculture, wellness, academic, and government sectors, across the research continuum.
"We are excited to partner with Metabolon, a company that has demonstrated innovation and excellence in the life sciences sector," said
This new growth capital will allow Metabolon to expand its research and development efforts to further enhance its metabolomics platform. The investment will also support the company's global expansion plans, including market penetration initiatives and strategic partnerships.
"We are extremely pleased to announce this successful financing with Trinity, marking a significant milestone for Metabolon. This infusion of additional capital and robust process leading up to it underscore the strong investor confidence in Metabolon's vision, capabilities, and market potential within the multiomics and metabolomics industry" said
About
Trinity (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth stage companies with institutional equity investors. Trinity's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans, equipment financings and equity-related investments. Trinity believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth stage companies. For more information, please visit the Company's website at www.trinitycap.com.
About Metabolon
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research and complement other 'omics' technologies. With more than 20 years, 10,000+ projects, 3,000+ publications, and ISO 9001:2015, CLIA, and CAP certifications, Metabolon has developed industry-leading scientific, technology, and bioinformatics techniques. Metabolon's
View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-60-million-in-growth-capital-to-metabolon-302146651.html
SOURCE
Vibhor Garg, Managing Director, Marketing, Trinity Capital, Inc., vgarg@trincapinvestment.com